Itau Unibanco Holding S.A. Trevena Inc Transaction History

Itau Unibanco Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$0.94 - $1.6 $6,142 - $10,456	-6,535 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$0.39 - $3.47 $184 - $1,637	472 Added 7.78%	6,535 $3,000
Q3 2018 Nov 13, 2018	SELL	$1.39 - $2.25 $262 - $425	-189 Reduced 3.02%	6,063 $13,000
Q2 2018 Aug 13, 2018	BUY	$1.44 - $2.24 $12 - $20	9 Added 0.14%	6,252 $9,000
Q1 2018 May 14, 2018	BUY	$1.51 - $2.06 $6,865 - $9,366	4,547 Added 268.1%	6,243 $10,000
Q4 2017 Feb 09, 2018	BUY	$1.4 - $2.6 $277 - $514	198 Added 13.22%	1,696 $3,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.79 $3,325 - $4,179	1,498	1,498 $12,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.